Advertisement
| cyclical hormone replacement therapy: Hormonal Contraception and Post-menopausal Hormonal Therapy IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1999 Evaluates evidence for an increased risk of cancer in women using combined oral contraceptives, progestogen-only hormonal contraceptives, post-menopausal estrogen therapy, and post-menopausal estrogen-progestogen therapy. Although the carcinogenicity of these preparations has been extensively investigated, the book stresses the many complex methodological issues that must be considered when interpreting findings and weighing results. Evidence of an association between use of these preparations and positive effects on health, including a reduced risk of some cancers, is also critically assessed. The first and most extensive monograph evaluates evidence of an association between the use of combined oral contraceptives and cancer at nine sites. Concerning breast cancer, the evaluation concludes that, even if the association is causal, the excess risk for breast cancer associated with patterns of use that are typical today is very small. Studies of predominantly high-dose preparations found an increased risk of hepatocellular carcinoma in the absence of hepatitis viruses. Citing these findings, the evaluation concludes that there is sufficient evidence in humans for the carcinogenicity of combined oral contraceptives. The evaluation also found sufficient evidence for the carcinogenicity of some, but not all, combined preparations in animals. Combined oral contraceptives were classified as carcinogenic to humans. The evaluation also cites conclusive evidence that these agents have a protective effect against cancers of the ovary and endometrium. Progestogen-only contraceptives are evaluated in the second monograph, which considers the association with cancer at six sites. The evaluation found no evidence of an increased risk for breast cancer. Although the evaluation found sufficient evidence in animals for the carcinogenicity of medroxyprogesterone acetate, evidence for the carcinogenicity of progestogen-only contraceptives in humans was judged inadequate. Progestogen-only contraceptives were classified as possibly carcinogenic to humans. The third monograph, on post-menopausal estrogen therapy, considers evidence of an association with cancer at eight sites. Findings from a large number of epidemiological studies indicate a small increase in the risk of breast cancer in women who have used these preparations for five years or more. Studies consistently show an association between use of post-menopausal estrogen therapy and an increased risk for endometrial cancer. Data on the association with other cancers were either inconclusive or suggested no effect on risk. The evaluation concludes that post-menopausal estrogen therapy is carcinogenic to humans. The final monograph evaluates the association between the use of post-menopausal estrogen-progestogen therapy and cancer at four sites. The evaluation of limited data on breast cancer found an increased relative risk observed with long-term use. Data were judged insufficient to assess the effects of past use and of different progestogen compounds, doses, and treatment schedules. For endometrial cancer, the evaluation found an increase in risk relative to non-users when the progestogen was added to the cycle for 10 days or fewer. Post-menopausal estrogen-progestogen therapy was classified as possibly carcinogenic to humans. Concerning post-menopausal therapy in general, the book notes that evidence of carcinogenic risks must be placed in perspective of potential benefits. The prevention of osteoporotic fractures is cited as the best-established benefit. Evidence also suggests that estrogen prevents heart disease and may prevent memory loss and dementia. |
| cyclical hormone replacement therapy: The Menopausal Transition Claudio N. Soares, Michelle P. Warren, 2009-01-01 The interplay of hormones, health and behavior across the female life cycle, especially during the menopausal transition, poses a special challenge to health care professionals.Written by experts, this book brings together the knowledge gained on the menopausal transition from clinical experience and medical research. Topics like 'what to expect' from the menopausal transition, sexuality, sociocultural changes, impact of life stressors, and emergence of depression are discussed. The physiology of thermoregulation and the occurrence of hot flashes are reviewed for a better understanding of vasomotor complaints. Another chapter offers an update on hormonal and nonhormonal treatment strategies by presenting an overview of the management of mood and anxiety during the menopausal transition. The emergence of psychotic symptoms associated with peri- and postmenopausal changes in sex hormone levels is also addressed. Lastly, the book includes an excellent review on the pros and cons of hormonal therapy in the post-Women's Health Initiative era. This book is a must for gynecologists, psychiatrists, endocrinologists, epidemiologists involved in the clinical care of mature women as well as researchers and students interested in obtaining an up-to-date overview of this topic. |
| cyclical hormone replacement therapy: The Greatest Experiment Ever Performed on Women Barbara Seaman, 2011-01-04 With the ardent tone of a close friend, Barbara Seaman draws on forty years of journalistic research to expose the menopause industry and shows how estrogen therapy often causes more problems—including breast cancer, heart attack, and stroke—than it cures. The Greatest Experiment Ever Performed on Women tracks the well-intentioned discovery of synthetic estrogen through the unconscionable and misleading promotion of a dangerous drug. |
| cyclical hormone replacement therapy: Menopause Dr. Louise Newson, 2019-09-24 This new Concise Manual takes a straightforward look at menopause. What is it? When does it occur? What can be expected? How can it be managed? Dr Louise Newson is a well-known specialist in menopause and saw the need for a fact-based manual for women and their families. Menopause is a natural condition that affects all women at some stage of their life. At least one in four women have severe symptoms, which detrimentally affect their family, home and work life. This book will explain and clarify the stages and symptoms, and detail what treatments are safe and effective for particular needs. Migraines, depression, anxiety, osteoporosis, low libido, relationships, diet and HRT are just some of the areas covered in this new concise manual. |
| cyclical hormone replacement therapy: Clinical Gynecology Eric J. Bieber, Joseph S. Sanfilippo, Ira R. Horowitz, Mahmood I. Shafi, 2015-04-23 Written with the busy practice in mind, this book delivers clinically focused, evidence-based gynecology guidance in a quick-reference format. It explores etiology, screening, tests, diagnosis, and treatment for a full range of gynecologic health issues. The coverage includes the full range of gynecologic malignancies, reproductive endocrinology and infertility, infectious diseases, urogynecologic problems, gynecologic concerns in children and adolescents, and surgical interventions including minimally invasive surgical procedures. Information is easy to find and absorb owing to the extensive use of full-color diagrams, algorithms, and illustrations. The new edition has been expanded to include aspects of gynecology important in international and resource-poor settings. |
| cyclical hormone replacement therapy: The Osteoporosis Manual Reiner Bartl, Christoph Bartl, 2019-02-06 This comprehensive manual covers all aspects of the prevention, diagnosis and management of osteoporosis, offering an upbeat and optimistic assessment of what can be achieved. While scientifically based, the book provides easy-to-follow guidelines for lifelong maintenance of skeletal structure and function. It deals with everything from the basic physiology of bone and mineral metabolism to the diagnostic utility of radiologic imaging and specialized tests and current treatment recommendations, including for fracture management. The relationship of osteoporosis to a variety of other disorders is also thoroughly explored and elucidated. Osteoporosis represents a global threat because every human being is vulnerable to it as time passes. The authors point out the enormous scale of the problem in terms of the human suffering, morbidity, and mortality on the one hand and the associated astronomical national and global costs on the other. Osteoporosis is preventable, and every doctor in every medical discipline can contribute to this goal. And though prevention is better than cure, it is never too late for effective therapy, as outlined in this book. Bone is every doctorʼs and every bodyʼs business! |
| cyclical hormone replacement therapy: Treatment of the Postmenopausal Woman Rogerio A. Lobo, 2007-06-05 For anyone who treats postmenopausal women, this latest edition of Rogerio Lobo's classic work combines the best from two well-known references: Menopause, and the second edition of Treatment of the Postmenopausal Woman. By adding significant discussions of the basic science behind menopause, it is possible to objectively assess the clinical value and limitations of current approaches to treatment and provide a basis and rationale for strategies that will result in better individualized and specialized care. Not only does the third edition discuss diagnosis and treatment of menopause but it covers biological, anatomical, physiological, pathobiological, and pharmacological aspects as well bringing together, in one source, all of the information needed to understand and treat postmenopausal conditions. Over 50% new material representing the vast amount of information available since the Women's Health Initiative (WHI) clinical trials were completed making this the most up-to-date reference on postmenopausal women Includes several new sections on comparisons between clinical trials and observational data, urology, and pelvic support Each section is preceded by a preface to put the area into context with many chapters having suggested treatment regimens |
| cyclical hormone replacement therapy: Ketamine for Treatment-Resistant Depression Gustavo H. Vazquez, Carlos A. Zarate, Elisa Brietzke, 2020-09-16 Ketamine for Treatment-Resistant Depression: Neurobiology and Applications provides a simple, evidence-based overview for neuropsychiatrists and translational researchers on this medication, its mechanisms of actions, eligibility of patients for treatment, and the preparation and implementation of ketamine clinics. - Provides efficacy research on ketamine as a treatment for depression - Identifies best practices for clinical use, both long-term and acute - Discusses the molecular mechanisms and neurobiology of action |
| cyclical hormone replacement therapy: Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research National Research Council, Division on Earth and Life Studies, Board on Life Sciences, Institute of Medicine, Board on Health Sciences Policy, Committee on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research, 2007-03-22 It is widely understood that stem cell treatments have the potential to revolutionize medicine. Because of this potential, in 2004 California voters approved Proposition 71 to set up a 10-year, $3 billion program to fund research on stem cells. Under the direction of the California Institute for Regenerative Medicine, this program will pay to build facilities for stem cell research and will fund doctors and scientists to carry out research with the ultimate goal of helping to develop therapies based on stem cells. For this research to move forward, however, will require a steady supply of stem cells, particularly human embryonic stem cells. Those stem cells are collected from developing human embryos created from eggs-or oocytes-harvested from the ovaries of female donors. Thus much of the promise of stem cells depends on women choosing to donate oocytes to the research effort. The oocyte donation process is not without risk, however. Donors are given doses of hormones to trigger the production of more eggs than would normally be produced, and this hormone treatment can have various side effects. Once the eggs have matured in the ovary, they must be retrieved via a surgical procedure that is typically performed under anesthesia, and both the surgery and the anesthesia carry their own risks. Furthermore, given the very personal nature of egg donation, the experience may carry psychological risks for some women as well. With this in mind, in 2006 the California Institute for Regenerative Medicine contracted with the National Academies to organize a workshop that would bring together experts from various areas to speak about the potential risks of oocyte donation and to summarize what is known and what needs to be known about this topic. The Committee on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research was formed to plan the workshop, which was held in San Francisco on September 28, 2006. This report is a summary and synthesis of that workshop. |
| cyclical hormone replacement therapy: Female Reproductive Dysfunction Felice Petraglia, Bart C. Fauser, 2020-05-29 Written by leading international specialists, this book provides a comprehensive, state-of-the-art overview of endocrine-based female reproductive disorders. Particularly focusing on the Hypothalamus – Pituitary – Ovary (HPO) axis as the main driver of reproduction in women, it discusses amenorrhea; chronic anovulation and polycystic ovary syndrome as the most common dysfunctions of the HPO axis; endocrine diseases as possible impacts on the HPO axis; uterine disorders related to estrogen/progesterone; and the impact of endometriosis and uterine fibroids on reproduction. It also addresses infertility and menopause as hormone-related disorders in women and endocrine changes during pregnancy and lactation, and in breast disorders. The book is intended as a major reference for endocrinologists, gynecologists, and obstetricians, as well as basic and clinical scientists. It is published as part of the SpringerReference program, which provides access to live editions constantly updated through a dynamic peer-review publishing process. |
| cyclical hormone replacement therapy: Lights Out T. S. Wiley, 2002-01-18 When it comes to obesity, diabetes, heart disease, cancer, and depression, everything you believe is a lie. With research gleaned from the National Institutes of Health, T.S. Wiley and Bent Formby deliver staggering findings: Americans really are sick from being tired. Diabetes, heart disease, cancer, and depression are rising in our population. We’re literally dying for a good night’s sleep. Our lifestyle wasn’t always this way. It began with the invention of the lightbulb. When we don’t get enough sleep in sync with seasonal light exposure, we fundamentally alter a balance of nature that has been programmed into our physiology since day one. This delicate biological rhythm rules the hormones and neurotransmitters that determine appetite, fertility, and mental and physical health. When we rely on artificial light to extend our day until 11 p.m., midnight, and beyond, we fool our bodies into living in a perpetual state of summer. Anticipating the scarce food supply and forced inactivity of winter, our bodies begin storing fat and slowing metabolism to sustain us through the months of hibernation and hunger that never arrive. Our own survival instinct, honed over millennia, is now killing us. Wiley and Formby also reveal: -That studies from our own government research prove the role of sleeplessness in diabetes, heart disease, cancer, infertility, mental illness, and premature aging -Why the carbohydrate-rich diets recommended by many health professionals are not only ridiculously ineffective but deadly -Why the lifesaving information that can turn things around is one of the best-kept secrets of our day. Lights Out is one wake-up call none of us can afford to miss. |
| cyclical hormone replacement therapy: Davis's Drug Guide for Rehabilitation Professionals Charles D. Ciccone, 2013-03-21 A one-of-a-kind guide specifically for rehabilitation specialists! A leader in pharmacology and rehabilitation, Charles Ciccone, PT, PhD offers a concise, easy-to-access resource that delivers the drug information rehabilitation specialists need to know. Organized alphabetically by generic name, over 800 drug monographs offer the most up-to-date information on drug indications, therapeutic effects, potential adverse reactions, and much more! A list of implications for physical therapy at the end of each monograph helps you provide the best possible care for your patients. It’s the perfect companion to Pharmacology in Rehabilitation, 4th Edition! |
| cyclical hormone replacement therapy: Ovarian Cycle Gerald Litwack, 2018-03-13 Ovarian Cycle, Volume 107, the latest in the Vitamins and Hormones series first published in 1943, and the longest-running serial published by Academic Press, covers the latest updates on hormone action, vitamin action, X-ray crystal structure, physiology and enzyme mechanisms. This latest release includes an overview of the ovarian cycle, a section on ovarian hyperstimulation syndrome, information on androgens and ovarian follicular maturation, information on peptide inhibitors of human thymidylate synthase to inhibit ovarian cancer cell growth, sections on nodal and luteolysis, neurokinins, dynorphin and pulsatile Lh secretion, Lh receptor expression by Mir12, and gonadotrophin-surge attenuating factor, melatonin and Bmp-6 regulation, amongst other topics. - Focuses on the newest aspects of hormone action in connection with diseases - Lays the groundwork for the focus of new chemotherapeutic targets - Reviews emerging areas in hormone action, cellular regulators and signaling pathways |
| cyclical hormone replacement therapy: Selected Practice Recommendations for Contraceptive Use World Health Organization. Reproductive Health and Research, World Health Organization, World Health Organization. Family and Community Health, 2005 This document is one of two evidence-based cornerstones of the World Health Organization's (WHO) new initiative to develop and implement evidence-based guidelines for family planning. The first cornerstone, the Medical eligibility criteria for contraceptive use (third edition) published in 2004, provides guidance for who can use contraceptive methods safely. This document, the Selected practice recommendations for contraceptive use (second edition), provides guidance for how to use contraceptive methods safely and effectively once they are deemed to be medically appropriate. The recommendations contained in this document are the product of a process that culminated in an expert Working Group meeting held at the World Health Organization, Geneva, 13-16 April 2004. |
| cyclical hormone replacement therapy: Genetics, Neurology, Behavior, and Diet in Dementia Colin R Martin, Victor R Preedy, 2020-08-11 Genetics, Neurology, Behavior, and Diet in Dementia: The Neuroscience of Dementia, Volume 2 consolidates different fields of dementia research into a single book, covering a range of subjects, including Alzheimer's disease, Lewy body dementia, mixed dementia, vascular dementia, physical activity, risk factors, mortality, biomarkers, SPECT, CT, MRI, questionnaires, nutrition, sleep, delirium, hearing loss, agitation, aggression, delusions, anxiety, depression, hallucinations, psychosis, senile plaques, tau and amyloid-beta, neuroinflammation, and molecular biology. This foundational, comprehensive book assembles the latest understanding on all dementias and their common features in a single source. It is an invaluable resource for neuroscientists, neurologists, and anyone in the field. - Offers comprehensive coverage of a broad range of topics related to dementia - Serves as a foundational collection for neuroscientists and neurologists on the biology of dementia and brain dysfunction - Contains in each chapter an abstract, key facts, mini dictionary of terms, and summary points to aid in understanding - Provides unique sections on specific subareas, intellectual components, and knowledge-based niches that will help readers navigate key areas for research and further clinical recommendations - Features preclinical and clinical studies to help researchers map out key areas for research and further clinical recommendations - Serves as a one-stop source for everything you need to know about dementia |
| cyclical hormone replacement therapy: Hormone Replacement: Therapy and Breast Cancer Risk R.D. Mann, 1992-07-15 This book covers a topic of considerable current interest and presents many of the most significant research findings available to date. Workers at the forefront of research on hormone replacement therapy and the implications for the risk of breast cancer were invited to attend a special Conference at the Royal Society of Medicine in London in September, 1991, where the latest data were presented to a distinguished audience and the implications of this research were discussed. The volume reviews various aspects of HRT and breast cancer, the physiology of the menopause, the current use of HRT in practice, osteoporosis and epidemiology and presents results from a range of European, American and Australian studies on the role of breast cancer and HRT, finishing with an overview of benefits, use and cost-effectiveness and a general summary. The book represents a definitive statement of current knowledge in this field and an informative update on the implications of recent research. It will be a valuable addition of special significance to the libraries of all those concerned with hormone replacement therapy and the study of breast cancer. |
| cyclical hormone replacement therapy: Hormonal Pathology of the Uterus Liane Deligdisch-Schor, Angelica Mareş Miceli, 2020-05-13 Hormonal influences, both natural and iatrogenic, are implicated in the most frequent health issues of women. Endometrial cancer is now the most common gynecologic cancer in the United States and the industrialized world. This cancer is strongly related to hormonal and metabolic factors. In addition, breast cancer treated with hormone therapy (Tamoxifen) may, in some cases, be associated with uterine pathology. Hormone therapy is used to improve the physiological effects and counteract abnormal and deleterious effects of “natural” hormonal activity. Millions of women receive hormone therapy at some point of their life: using oral contraceptives, reproductive technology, treatment for post-menopausal symptoms, among other uses. This book addresses a range of women’s health issues, from fertility to neoplasms, and their relationship with natural and iatrogenic hormonal effects. Chapters include clinical and pathological descriptions, theoretical and practical medical issues, and original studies and cases. Controversial issues in certain hormone therapies are presented with updated concepts based on clinical studies and novel statistical methods. The book will be useful for specialized and general physicians, oncologists, endocrinologists, researchers, medical students, and others in the field of women’s health. |
| cyclical hormone replacement therapy: Medical Eligibility Criteria for Contraceptive Use , 2010 Medical Eligibility Criteria for Contraceptive Use reviews the medical eligibility criteria for use of contraception, offering guidance on the safety and use of different methods for women and men with specific characteristics or known medical conditions. The recommendations are based on systematic reviews of available clinical and epidemiological research. It is a companion guideline to Selected Practice Recommendations for Contraceptive Use. Together, these documents are intended to be used by policy-makers, program managers, and the scientific community to support national programs in the preparation of service delivery guidelines. The fourth edition of this useful resource supersedes previous editions, and has been fully updated and expanded. It includes over 86 new recommendations and 165 updates to recommendations in the previous edition. Guidance for populations with special needs is now provided, and a new annex details evidence on drug interactions from concomitant use of antiretroviral therapies and hormonal contraceptives. To assist users familiar with the third edition, new and updated recommendations are highlighted. Everyone involved in providing family planning services and contraception should have the fourth edition of Medical Eligibility Criteria for Contraceptive Use at hand. |
| cyclical hormone replacement therapy: Menopause Antonio Cano, 2017-11-02 This book provides an evidence-based approach to the universal experience of menopause. Its structured format clearly separates the biological basis from the clinical impact and quality of life, while also examining menopause within the context of healthy ageing in females. Accordingly, the book addresses factors including lifestyle, frailty, sarcopenia, and new ICT technologies. Written by respected experts in the field, the book offers a valuable guide for gynecologists and professionals devoted to women’s healthcare and ageing quality of life, while also sharing revealing insights for non-professionals. |
| cyclical hormone replacement therapy: Geriatric Rehabilitation Manual Timothy L. Kauffman, John O. Barr, Michael L. Moran, 2007-01-01 This manual gives step-by-step guidance on the evaluation and treatment of geriatric diseases and disorders. It covers incidence of disorders, diagnostic tests, associated diagnoses, clinical implications for mobility, and rehabilitation techniques. It offers a broad overview of the effects of aging on all body systems. Special geriatric considerations for laboratory assessment, thermoregulations, and pharmacology are also discussed. This manual is a resource for all training clinicians in geriatric care and is a quick-reference guide for students and practitioners in this field. |
| cyclical hormone replacement therapy: The Menopause Risto Erkkola, 2006-01-01 EUROPEAN PRACTICE IN GYNAECOLOGY AND OBSTETRICT is a series of books conceived and endorsed by the European Board and College of Obstetrics and Gynaecology (EBCOG). Its aim is to provide up-to-date, evidence-based information that represents the consensus of opinion among leading European experts in the field, as part of the overall aim of standardising training and practice in order to ensure quality care and facilitate exchange among physicians in all parts of Europe and the rest of the world. |
| cyclical hormone replacement therapy: Sex, Lies, and Menopause T. S. Wiley, Julie Taguchi, Bent Formby, 2009-10-13 “A new hypothesis, post Women’s Health Initiative, that must be examined further by the entire scientific community.” —Allison Mayer-Oakes, M.D., M.S.P.H., F.A.C.P, founder of the Longevity Medical Center of Santa Barbara Turning thirty years of medical and cultural wisdom on its head, Sex, Lies, and Menopause challenges both the medical establishment and modern feminists to prove that menopause does not have to be deadly. In this revolutionary work—a landmark that signals the true beginning of feminist medicine—a doctor, a philosopher, and a scientist prove that by postponing marriage and motherhood, women have accelerated the aging process, resulting in earlier menopause and, ultimately for thousands, earlier death. In Sex, Lies, and Menopause, T. S. Wiley, Julie Taguchi, M.D., and Bent Formby, Ph.D., offer strong evidence that the use of synthetic hormones leads to cancer and advise women to turn to natural hormone-replacement therapy—derived from plants, not drugs—to help them elevate their estrogen level for greater energy, libido, and intellectual capacity. Provocative, empowering, and scientifically sound, Sex, Lies, and Menopause addresses the inherent benefits of natural progesterone, reveals the lies advanced by the medical and drug establishments, and challenges women to demand a medical future where their health comes first. The research presented in Sex, Lies, and Menopause will at last allow women to create their own plan of action to put themselves safely on the path to better health and hormonal balance at any stage of life. |
| cyclical hormone replacement therapy: Hormone Replacement Therapy and Cardiovascular Disease A.R. Genazzani, 2001-05-15 This is a high-level, clinical reference by world-class specialists on the efficacy of hormone replacement therapy for the primary prevention of cardiovascular risk in postmenopausal women. Specific chapters cover pulsed estrogen therapy with Aerodiol and cardiovascular risk assessment in postmenopausal hormone replacement therapies such as Livial (tibolone). This volume is based on the formal presentations and subsequent discussions that took place at the International Menopause Society specially convened Expert Workshop on Hormone Replacement Therapy and Cardiovascular Disease, London, UK, October 13-16, 2000. |
| cyclical hormone replacement therapy: The Pituitary Shlomo Melmed, 2010-12-09 The pituitary, albeit a small gland, is known as the master gland of the endocrine system and contributes to a wide spectrum of disorders, diseases, and syndromes. Since the publication of the second edition of The Pituitary, in 2002, there have been major advances in the molecular biology research of pituitary hormone production and action and there is now a better understanding of the pathogenesis of pituitary tumors and clinical syndromes resulting in perturbation of pituitary function. There have also been major advances in the clinical management of pituitary disorders. Medical researchers and practitioners now better understand the morbidity and mortality associated with pituitary hormone hyposecretion and hypersecretion. Newly developed drugs, and improved methods of delivering established drugs, are allowing better medical management of acromegaly and prolactinoma. These developments have improved the worldwide consensus around the definition of a cure for pituitary disease, especially hormone hypersecretion, and hence will improve the success or lack of success of various forms of therapy. It is therefore time for a new edition of The Pituitary. The third edition will continue to be divided into sections that summarize normal hypothalamic-pituitary development and function, hypothalamic-pituitary failure, and pituitary tumors; additional sections will describe pituitary disease in systemic disorders and diagnostic procedures, including imaging, assessment of the eyes, and biochemical testing. The first chapter will be completely new – placing a much greater emphasis on physiology and pathogenesis. Two new chapters will be added on the Radiation and Non-surgical Management of the Pituitary and Other Pituitary Lesions. Other chapters will be completely updated and many new author teams will be invited. The second edition published in 2002 and there have been incredible changes in both the research and clinical aspects of the pituitary over the past 8 years – from new advances in growth hormones to pituitary tumor therapy. - Presents a comprehensive, translational source of information about the pituitary in one reference work - Pituitary experts (from all areas of research and practice) take readers from the bench research (cellular and molecular mechanism), through genomic and proteomic analysis, all the way to clinical analysis (histopathology and imaging) and new therapeutic approaches - Clear presentation by endocrine researchers of the cellular and molecular mechanisms underlying pituitary hormones and growth factors as well as new techniques used in detecting lesions (within the organ) and other systemic disorders - Clear presentation by endocrinologists and neuroendocrine surgeons of how imaging, assessment of the eyes, and biochemical testing can lead to new therapeutic approaches |
| cyclical hormone replacement therapy: The Sexy Years Suzanne Somers, 2004-03-09 Getting older can be brutal—women gain weight, lose their sex drive, experience hot flashes, suffer memory loss, become short-tempered, find it difficult to sleep, and on and on. It’s not so easy for men, either—they start to lose energy and stamina as they age, too (and they have to live with women going through menopause). After years of being thin and fit and full of energy, Suzanne herself encountered the “Seven Dwarfs of Menopause”—Itchy, Bitchy, Sweaty, Sleepy, Bloated, Forgetful, and All-Dried-Up. Instead of living out the rest of her life cranky, sleep-deprived, and libido-less, Suzanne set out to discover how she could get her mind, body, and life back and banish those pesky dwarfs for good. The result is The Sexy Years: Discover the Hormone Connection—The Secret to Fabulous Sex, Great Health, and Vitality, for Women and Men. In this passionately argued and enormously practical book, Suzanne supports her own research and experiences with the expertise of leading doctors in the field of women’s and men’s health and sexuality to create an inspiring, accessible call-to-arms to women to radically rethink how they approach life after fifty, and give them the tools to turn their lives around. Suzanne has discovered that the second half of life has been more rewarding, fun, and purposeful than her younger years. The key to her happiness? Taking natural bioidentical hormones. Natural hormones, which mimic the hormones produced in our own bodies that are almost completely lost with aging, are the answer to the symptoms of menopause that plague women. Recent findings from the medical community show that synthetic hormone replacement therapy (HRT) may be harmful to women—thus, thousands of women are looking for what else they can do to alleviate their symptoms. In The Sexy Years, Suzanne comes to the rescue with a step-by-step plan and detailed information about how women can take control of their health, for themselves and for their men, including: • What the differences are between synthetic and bioidentical hormones, and why bioidentical hormones help women lose weight, reinvigorate their sex lives, and fight the symptoms of aging • How doctors do not receive adequate training about hormones and are slaves to the pharmaceutical industry, and what questions every woman must ask her physician about hormone replacement therapy and her health • How Suzanne turned her life around, with information about how often she visits her doctor, blood work, what hormones she takes, how to get these hormones, and more • What male menopause, or andropause, is and how men can also take bioidentical hormones and regain the energy they had in their youth • What a variety of specialists think about natural hormones, health, and sexuality—Suzanne shares the best advice from these doctors and provides a resource list of physicians and pharmacies With bioidentical hormone replacement therapy, Suzanne has found the fountain of youth, the elixir that has made her feel thirty years old again. In combination with her Somersize diet and fitness plan, which she also writes about here, Suzanne has never felt better. The beauty of growing older, she maintains, is that you can combine the wisdom of age with the vitality of youth. Suzanne makes it perfectly clear how women and men can regain their zest for life at any age. These really are the sexy years! |
| cyclical hormone replacement therapy: Endocrinology of Aging Emiliano Corpas, Marc R. Blackman, Ricardo Correa, S. Mitchell Harman, Antonio Ruiz-Torres, 2020-09-25 According to the United Nations, the number of people aged 60 years or over in the world is projected to be 1.4 billion in 2030 and 2.1 billion in 2050. Endocrinologists and other clinicians face the challenge of caring for the elderly. To do so, they need to incorporate geriatric principles into their clinical practice. Endocrinology of Aging: Clinical Aspects in Diagrams and Images presents chapters in a way that allows the reader to incorporate concepts and main facts of complex subjects in a visual way. As the global population becomes older, the need for a deeper understanding of geriatric pathology increases, and with it, the access to educational resources for the endocrinology and metabolism of aging. - Chapters divided according to specific endocrine and metabolic systems, providing evidence-based content regarding what is known about the function of endocrine and metabolic systems altered during the aging process - Addresses physiological changes that alter the pathophysiology of the clinical picture, explaining the characteristic pathological expressions of hormonal and metabolic disorders in the advanced age - Editors and authors are clinical endocrinologists, geriatricians, internists and endocrine surgeons, with extensive global experience in clinical and experimental gerontology - Considers the patient transitioning from young adult to elderly, discussing the endocrinological challenge to discern physiology from pathology - Focuses on age as an essential factor for diagnostic and endocrine management - Includes many pictures and diagrams, making it a user-friendly reference guide for practicing physicians |
| cyclical hormone replacement therapy: Dr. John Lee's Hormone Balance Made Simple John R. Lee, Virginia Hopkins, 2008-12-14 From the bestselling authors of the classic What Your Doctor May NOT Tell You books about menopause and pre-menopause comes an easy-to-use guide on balancing hormone levels safely and naturally. Dr. John Lee will help you answer key questions like: Are my symptoms caused by a hormonal imbalance? Which hormones do I need to regain hormone balance? How do I use hormones for optimal health and balance? Plus, learn how and when to use estrogen, testosterone and progesterone cream, in simple, effective language. If you want the ABCs of using natural hormones, this book is for you. |
| cyclical hormone replacement therapy: The Hormone of Desire Susan Rako, 1996 Millions of women experience a traumatic loss of sexual desire during menopause. Although estrogen and progesterone alleviate many of the effects of menopause, they cannot address flagging sexual desire. This first book to reveal the benefits of testosterone supplements for menopausal women will be an invaluable tool for women and their doctors. |
| cyclical hormone replacement therapy: Estrogen Matters Carol Tavris, Avrum Bluming, 2018-09-04 A compelling, “fascinating” (Robert Cialdini) defense of hormone replacement therapy, exposing the faulty science behind its fall from prominence and giving women the evidence they need to make informed decisions about their health. Now fully revised and updated. Estrogen Matters was my antidote to the misinformation surrounding menopause. This book should be the bible for every single person going through menopause.”―Naomi Watts For years, hormone replacement therapy (HRT) was the medically approved way to alleviate menopausal symptoms (ranging from hot flushes to brain fog) and reduce the risk of heart disease, Alzheimer's, and osteoporosis. But when a large study by the Women's Health Initiative (WHI) announced, with national fanfare, that women taking HRT had an increased risk of breast cancer, women were scared off, and the treatment was abandoned. Now, Dr. Bluming, a medical oncologist, and Dr. Tavris, a social psychologist, reveal the true story of the WHI’s efforts to distort their data to exaggerate unsupported claims of estrogen’s harms. Important updates in this edition include: Evidence that demolishes the WHI’s claim that HRT causes breast cancer. A list of the WHI’s retractions of their original scare stories. Updated findings on estrogen’s benefits on heart, brain, bones, and longevity. A critical review of the alternative products and medications being marketed to treat symptoms of menopause. A sobering and revelatory read, Estrogen Matters sets the record straight on estrogen’s benefits, providing a light to guide women through this inevitable phase of life. |
| cyclical hormone replacement therapy: Research on the Menopause in the 1990s , 1996 This report reviews current research on the menopause, including studies on its symptons and their treatment, and its effects on the cardiovascular and skeletal systems. It also assesses the relevance of existing data to women in developing countries. |
| cyclical hormone replacement therapy: The Estrogen Errors Susan Baxter, 2009-05-19 The Women's Health Initiative study in the 1990s upended the conventional wisdom concerning hormone replacement therapy for menopausal women. Medical writer Baxter (Simon Fraser U.) and Prior (medicine, U. of British Columbia) trace the history of the estrogen-deficiency disease paradigm of menopause. Instead of the myth that estrogen is a female hormone that needs replenishing, these self-identified feminists advocate consideration of the complexities of what is 'normal' and the use of progesterone among options to ease menopausal symptoms. Appendices include further information about perimenopause, the forgotten transition, and menopause management. Annotation ©2009 Book News, Inc., Portland, OR (booknews.com). |
| cyclical hormone replacement therapy: Progesterone and Progestins C. Wayne Bardin, Edwin Milgröm, P. Mauvais-Jarvis, 1983 |
| cyclical hormone replacement therapy: Hormone Replacement Therapy A. Wayne Meikle, 1999-06-01 A. Wayne Meikle and a distinguished panel of expert clinicians bring to bear their extensive knowledge and experience in managing adults and children undergoing hormone replacement therapy for the pituitary, parathyroid, thyroid, pancreas, adrenal glands, and gonads. Emphasizing proper patient management, the book provides to specialists and general practitioners alike time-tested, cutting-edge guidelines on the use, monitoring, and dosage of hormone therapeutics in the treatment of disorders of endocrine function, while giving an exhaustive analysis of each therapy. Comprehensive and eminently practical, Hormone Replacement Therapy captures the most recent advances in hormone replacement therapeutics and is certain to serve endocrinologists, gynecologists, pediatricians, urologists, internists, and family practitioners as today's standard reference for managing and monitoring their patients. |
| cyclical hormone replacement therapy: The Prescriber's Guide to Hormone Replacement Therapy M.I. Whitehead, 1998-08-15 Drawing together many of the world's foremost experts, this book provides clear and specific guidance about the prescription of hormone replacement therapy. It covers prescribing for patients with a wide range of pre-existing diseases. In each instance, expert advice is given with reference to the latest published research. There is also an overview of other key issues affecting the choice of therapy. |
| cyclical hormone replacement therapy: A New Prescription for Women's Health Bernadine Healy, 1996 The first female director of the National Institutes of Health addresses the inequities in women's health care, informing women about their major health concerns and empowering them to demand better care. Confidential to females from 19 to 96: Treat yourself to a splendid book.--Ann Landers. |
| cyclical hormone replacement therapy: Feminine Forever Robert A. Wilson, 2000-07 |
| cyclical hormone replacement therapy: Hormone Replacement Therapy Studies Sara T. Goulden, 2003-07-29 This reference work serves those individuals needing thorough and accurate information about hormone replacement therapy (HRT) and the studies about the downside of its use. It presents research information and scientific data so that health care workers and their female clients can ask informed questions and make intelligent decisions about HRT. This book objectively presents summaries of significant clinical and epidemiological studies of HRT and risks of breast cancer, osteoporosis, heart disease, endometrial cancer, ovarian cancer and other conditions. Each study is organized by citation of research, researchers/authors, type of study, focus of study, conclusions, findings, researchers' comments, participants and methods. References and a glossary aid readers with terminology and encourage cross-referencing. |
| cyclical hormone replacement therapy: Hormone Replacement Therapy: Standardized or Individually Adapted Doses? C. Christian, B. von Schoultz, 1994-03-15 This volume raises the question whether hormone replacement therapy should be given in standardized doses or in a regimen adapted to the individual woman. The effect on bone mass, amenorrhea, long-term changes in the endometrium and compliance are all discussed. |
| cyclical hormone replacement therapy: Menopause For Dummies Dr. Sarah Brewer, Marcia L. Jones, Theresa Eichenwald, 2011-02-15 Every woman experiences the menopause in different ways, so you need to know what to expect in order to help yourself. This book explains the various stages of the menopause, including the perimenopause, and helps you understand how it can affect your body and your emotions. It evaluates all the options available—including HRT and explains what treatment and lifestyle changes will help you stay healthy and happy. With in-depth coverage of HRT, covering new developments and weighing up the risks and benefits, advice on adopting an holistic approach to managing the symptoms and side effects including conventional medicine, and alternatives, diet and lifestyle changes, Menopause For Dummies will help you make the right decisions and stay in control. |
| cyclical hormone replacement therapy: Journal of the National Cancer Institute , 2005 |
CYCLICAL Definition & Meaning - Merriam-Webster
The meaning of CYCLIC is of, relating to, or being a cycle. How to use cyclic in a sentence.
CYCLICAL | English meaning - Cambridge Dictionary
CYCLICAL definition: 1. Cyclical events happen in a particular order, one following the other, and are often repeated…. Learn more.
Cyclical - Definition, Meaning & Synonyms | Vocabulary.com
Cyclical is used to describe things that are regularly patterned or that occur in regular intervals. The root of cyclical is “cycle” which means movement in a circular fashion, or the circular …
68 Synonyms & Antonyms for CYCLICAL - Thesaurus.com
Find 68 different ways to say CYCLICAL, along with antonyms, related words, and example sentences at Thesaurus.com.
Cyclical - definition of cyclical by The Free Dictionary
Of, relating to, or characterized by cycles: a cyclic pattern of weather changes. b. Recurring or moving in cycles: cyclical history. 2. Chemistry Of or relating to compounds having atoms …
What does Cyclical mean? - Definitions.net
Cyclical refers to any event, process, pattern, or situation that recurs or repeats in a cycle or a circular manner. It generally refers to phenomena that can be observed to occur in a …
cyclical - Wiktionary, the free dictionary
Apr 10, 2025 · cyclical (comparative more cyclical, superlative most cyclical) Nobody thinks the cyclical turn is possible until it's already well underway. (botany) Rolled up circularly. cyclical …
CYCLICAL - Definition & Translations | Collins English Dictionary
Discover everything about the word "CYCLICAL" in English: meanings, translations, synonyms, pronunciations, examples, and grammar insights - all in one comprehensive guide.
Cyclical Definition & Meaning - YourDictionary
Tending to rise and fall in line with the fluctuations of the business cycle. Cyclical stocks. Recurring at regular intervals. Its tendency to undergo cyclical changes.
cyclical, adj. meanings, etymology and more - Oxford English …
What does the adjective cyclical mean? There are eight meanings listed in OED's entry for the adjective cyclical . See ‘Meaning & use’ for definitions, usage, and quotation evidence.
BMS & WHC’s 2020 recommendations on hormone …
on hormone replacement therapy in menopausal women CONTENTS Executive summary 2 Introduction 4 Table 1 – Risk of cancer 5 with HRT and safety of HRT after cancer diagnosis …
Management of Unscheduled Bleeding on Hormone …
bleeding on hormone replacement therapy. This summary guide contains the tables and appendices from the guideline in a quick look format and is intended to support clinical …
HKCOG Guidelines Number 2 Revised November 2006 …
4 PRESCRIPTION OF HORMONE REPLACEMENT THERAPY For the purpose of hormone replacement, oestrogen may be administered orally, percutaneously, transdermally, in a …
Managing menopausal symptoms - RANZCOG
most suitable therapy.28 Consensus-based recommendation Recommendation 18 Grade Short term (1-2 years) use of vaginal oestrogen appears to be safe, though long-term data are …
Making choices at menopause - Royal Australian College of …
hormone therapy (MHT). To ensure women can make an informed choice about whether to use MHT, it is important for them to receive balanced and accurate information about the benefits …
North Yorkshire and York Menopause Guidance – HRT
progestogen phase of cyclical hormone replacement therapy (HRT). At annual review check efficacy, side-effects, ensure correct dose, optimal route of delivery and compliance. Also …
CLINICAL PRACTICE GUIDELINES: Management Of …
5.8 (ii) Cyclical therapy with absent scheduled bleeding 47 5.9 Choice of Estrogen in Menopausal Hormone Therapy 48 5.10 Choice of Progestogen in Menopausal Hormone Therapy 49 ... till …
Bioidentical HRT - British Menopause Society
Simon J. What’s new in hormone replacement therapy: focus on transdermal estradiol and micronised progesterone. Climacteric. 2012; Suppl 1:3-10. Vinogradova Y, Coupland C, …
Menopausal hormone replacement therapy - Menopause …
HORMONE replacement therapy (HRT) is the most effective treatment for relief of menopausal vasomotor symptoms. 1 Before 2002, level 2 observational studies2,3 of symptomatic women …
Hormone replacement therapy
Hormone replacement therapy Hormone replacement therapy can replace either oestrogen alone or oestrogen and progesterone that the ovaries are no longer producing, the idea being to …
AMS Guide to MHT/HRT Doses - menopause.org.au
available in New Zealand in September 2024. Hormone Replacement Therapy (HRT) is now referred to as Menopausal Hormone Therapy (MHT). The intention of this sheet is to help …
The Basics of BHRT Bio-Identical Hormone Replacement …
Bio-Identical Hormone Replacement Therapy Linda Haggard, MPAS, PA-C March 6, 2014 ASAPA 2014 Primary Care Conference 2 What are Bio-Identical Hormones? Although many …
An examination of the effect of combined cyclical hormone …
This study demonstrates that combined cyclical hormone replacement therapy is effective in reducing concentrations of Lp(a). The trend towards a more atherogenic lipid profile during the
Managing Unscheduled Bleeding In Women on Hormone …
In Women on Hormone Replacement Therapy Trust ref: C66/2023 ... B. Cyclical HRT regimens . Increase the dose or duration of progesterone: • For women on a regime that already includes …
Combined Hormone (Replacement) Therapy - Menopause
Combined menopausal hormone therapy may be given as “cyclical”, where the oestrogen is given daily and the ... 5. Canonico M, Plu-Bureau G, Lowe GDO, Scarabin P-Y. Hormone …
A comparison of the effects of lipoproteins of two …
Hormone replacement therapy (HRT) relieves the distressing physical symptoms caused by the menopause [l] and prevents the subsequent rapid loss of bone [2,3]. Endometrial hyperplasia …
Menopausal Hormone Therapy - Jean Hailes
as menopausal hormone therapy (MHT). What is MHT and how does it help? MHT is the replacement of female hormones oestrogen and progesterone, and sometimes testosterone. …
YOUR GUIDE TO MENOPAUSAL HORMONE THERAPY WITH …
known as hormone replacement therapy (HRT), is used to ease symptoms of menopause.2-4 Estrogen is the main hormone prescribed to ease menopausal symptoms; it works by …
An examination of the effect of combined cyclical hormone …
An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins Christopher J. JHaines *’ , Tony K.H. Chung”, John R.L. Masareib, Brian …
Menopause and menopausal symptoms - Department of Health
Menopausal hormone therapy (MHT) (previously known as hormone replacement therapy (HRT)) Menopausal hormone therapy is the most effective treatment for vasomotor symptoms, …
Hormone Replacement Therapy (HRT) - Cedar Practice
Vaginal oestrogen cream and other topical preparations For vaginal dryness (atrophic vaginitis) or bladder symptoms, you may choose to try a vaginal oestrogen cream or a pessary to help
A Practical Guide to Prescribing Hormone Replacement …
Hormone Replacement Therapy Karen A. McKinney and William Thompson ... uterus in a cyclical or continuous regimen. The management of common estro-genic and progestogenic adverse …
Menopausal hormone therapy - The Royal Women's Hospital
Menopausal hormone therapy (MHT) was previously known as hormone replacement therapy (HRT). It contains oestrogen plus a progestogen, or oestrogen alone for women who have had …
Statement of Principles
"MET" means a unit of measurement of the level of physical exertion. 1 MET = 3.5 ml of oxygen/kg of body weight per minute or, 1.0 kcal/kg of body weight per hour, or resting …
Induced menopause in women with endometriosis - British …
may resolve. Inducing menopause will stop ovarian cyclical activity and he nce cyclical stimulation of endometriotic deposits. The methods of inducing menopause are: Gonadotrophin releasing …
3006 Esplanade, Suite 'I', Chico, CA 95973 Phone: 345-7979 …
Saliva testing will help establish baseline levels and better correlate the symptoms a woman is experiencing to hormone levels in the body. ... do not stop synthetic estrogen replacement …
YOUR GUIDE TO MENOPAUSAL HORMONE THERAPY WITH …
female hormone progesterone.5,6 These two hormones are identical to the hormones produced naturally in your body.5-7 Estrogel Pro can only be prescribed by a doctor, and is for women …
Ovarian cysts and cyclic hormone replacement therapy: is …
Hormone replacement therapy is associated with a reduced prevalence of ovarian cysts in early postmenopause. Key words: hormone replacement therapy; menopause; ovarian cyst …
Hormone Replacement Therapy - content.teladochealth.com
Hormone replacement therapy (HRT) is used to treat the symptoms of menopause. These symptoms are a direct result ... Cyclical HRT If you are perimenopausal and therefore still …
Statement of Principles
oestrogen-only hormone replacement therapy has ceased, the clinical onset of malignant neoplasm of the endometrium has occurred within twenty years of cessation; or (iii) having …
Progestin-related breast volume changes in a woman with …
during biphasic hormone replacement therapy consisting of estradiol and cyclical dydrogesterone, a progestin. 3D breast volume measurements showed a 100 cc volume (17%) difference …
Hormone Replacement Therapy (HRT) - drtava.co.nz
Vaginal oestrogen cream and other topical preparations For vaginal dryness (atrophic vaginitis) or bladder symptoms, you may choose to try a vaginal oestrogen cream or a pessary to help
Menopause Hormone therapy - RACGP
symptom relief and risk prevention; hormone therapy or nonhormonal alternatives for symptom relief; prevention and treatment of long term risks; and education and psychological support …
Hormone replacement therapy guidelines Guidelines for the ...
(3.2) Combined cyclical (sequential) hormone replacement therapy A cyclical (sequential) regimen implies that a pro-gestogen is given on a cyclical basis (in addition to oestrogen) [Table 1b]. …
in Canada for the Treatment of Menopausal Symptoms
replacement therapy to significantly reduce the risk of endometrial hyperplasia and carcinoma Medroxypro- gesterone acetate PROVERA Pfizer Canada Inc. Tablet 2.5 mg 5 mg 10 mg …
Research letter Possibilities of sterility therapy in a patient …
of a cyclical hormone replacement therapy followed by gonadotrophin stimulation, as well as a second time under down-regulation with a GnRH-analogue and gonadotrophin stimulation. On …
Statement of Principles concerning malignant neoplasm of …
endometrium, and where the use of oestrogen-only hormone replacement therapy has ceased, the clinical onset of malignant neoplasm of the endometrium has occurred within 30 years of …
Fibrocystic Breast Changes
menopause, and longer if hormone replacement therapy is used. When the hormone levels are high the week or so before a woman’s menstrual period starts, the breast tissue blood vessels …
Statement of Principles concerning malignant neoplasm of the ...
(3) having cyclical combined hormone replacement therapy where oestrogen is combined with cyclical administration of progesterone for less than 15 days during each treatment cycle, for a …
Information for you - Royal College of Obstetricians
Cognitive behavioural therapy (CBT) is a type of psychological treatment. You may be offered CBT for low mood or anxiety related to menopause. Hormone replacement therapy (HRT) …
Guideline No. 422a: Menopause: Vasomotor Symptoms, …
2. Menopausal hormone therapy is the most effective option for managing moderate to severe vasomotor symptoms. 3. Non-hormonal prescription therapies are options to treat vasomotor …
Information for women HRT: Beneits and risks - Women's …
which are claimed to be safer than “traditional” hormones used in hormone repl acement therapy (HRT). In fact, some traditional HRT preparations are actually “bio-identical ”, using oestradiol …
Can endometrial protection be inferred from the bleeding …
Keywords:Endometrial protection; Bleeding pattern; Hormone replacement therapy www.elsevier.com:locate:maturitas 1. Introduction The use of unopposed oestrogen …
Menopause and HRT
Hormone replacement therapy (HRT) may ease symptoms. However, if you take HRT ... Monthly cyclical HRT - you take oestrogen every day, but progestogen is added in for 14 days of each …
AACE Releases Guidelines for Menopausal Hormone Therapy …
Menopausal hormone therapy is the most effec-tive treatment for these symptoms. The goal of this therapy is to improve quality of life, but possible risks
Unscheduled bleeding with hormone replacement therapy
Keywords: hormone replacement therapy / menopause / unscheduled bleeding Please cite this paper as: Dave FG, Adedipe T, Disu S, Laiyemo R. Unscheduled bleeding with hormone …
UNSCHEDULED BLEEDING ON HRT
BMS | GUIDELINE Management of unscheduled bleeding on hormone replacement therapy (HRT) 6 | 47 Copyright © 2024 British Menopause Society. All rights reserved ...
Serum Lipids, Lipoproteins, and Apolipoproteins During …
hormone replacement therapy on levels of serum lipids, lipoproteins, and apolipoproteins. PATIENTSANDMETHODS: Gnehundredthirty- nine healthy early postmenopausal women se- …
INFORMATION SHEET - goldcoastwomencare.com.au
July 2018. HRT is now referred to as Menopausal Hormone Therapy (MHT). The intention of this sheet is to help physicians change their patients to higher or lower approximate doses of MHT …
